IDTA
IDenta Corp. develops, manufactures, and supplies field detection and home diagnostics testing kits for narcotics and explosives, and forensic products in the homeland security and consumer markets worldwide. The company offers drug, explosives, and bullet-hole testing kits; FerroPrint testing products; blood detection kits; precursors of drugs test kits; and portable sniffers. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. IDenta Corp. was incorporated in 1997 and is headquartered in Jerusalem, Israel.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.01 | $520,983 | -$34,890 |
| 2025 Q4 | 0.02 | $396,911 | $220,331 |
| 2025 Q3 | 0.02 | $427,519 | $70,990 |
| 2025 Q2 | 0.00 | $341,811 | -$186,082 |
| 2025 Q1 | -0.02 | $174,799 | -$64,961 |
| 2024 Q4 | -0.02 | $299,284 | $103,300 |
| 2024 Q3 | 0.03 | $366,870 | $185,194 |
| 2024 Q2 | 0.02 | $360,988 | $73,184 |